Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody

The COVID-19 pandemic has reemphasized the need to identify safe and scalable therapeutics to slow or reverse symptoms of disease caused by newly emerging and reemerging viral pathogens. Recent clinical successes of monoclonal antibodies (mAbs) in therapy for viral infections demonstrate that mAbs o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeitlin, Larry, Cross, Robert W., Geisbert, Joan B., Borisevich, Viktoriya, Agans, Krystle N., Prasad, Abhishek N., Enterlein, Sven, Aman, M. Javad, Bornholdt, Zachary A., Brennan, Miles B., Campbell, Lioudmila, Kim, Do, Mlakar, Neil, Moyer, Crystal L., Pauly, Michael H., Shestowsky, William, Whaley, Kevin J., Fenton, Karla A., Geisbert, Thomas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2021
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980402/
https://www.ncbi.nlm.nih.gov/pubmed/33836604
http://dx.doi.org/10.1073/pnas.2023332118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980402/
https://www.ncbi.nlm.nih.gov/pubmed/33836604
http://dx.doi.org/10.1073/pnas.2023332118

Ejemplares similares